Digital Better analytics leads to fewer regulator questions Stronger data analytics is cutting the number of questions regulators ask about intensified processes.
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
R&D Partner Content Register Now for the AAPS National Biotechnology Conference The AAPS National Biotechnology Conference uncovers the trends driving today’s biotech markets.
Market Access Why the NHS needs to maximise the impact of biosimilars Ensuring the long-term sustainability of the NHS increasingly appears to be an unfathomable prospect.
News AMD shadows NVIDIA with a move into AI drug discovery Chipmaker AMD has taken a 20% stake in Absci, a specialist in the use of artificial intelligence in for biologic drug discovery.
News Sanofi opens $595m manufacturing facility in Singapore Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products
News Flagship joins three biotechs together to form Etcelera Flagship Pioneering has formed a new AI-focused biotech company, called Etcelera, by combining the platforms of three firms from its portfolio.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
